Corporate Presentation Corporate Presentation ASN 2022 Presentations A Randomized Phase 2 Study of MAU868 vs Placebo to Treat BK Viremia in Kidney Transplant Recipients – Week 36 Results Atacicept Reduces Serum Immune Complex Levels in IgAN Patients ERA EDTA 2022 Presentations 2022 ERA EDTA April SLE Renal 2022 ERA EDTA anti GdlgA1 ASN 2021 E-Poster Presentation Atacicept Reduces Serum Gd-IgA1 by Quartiles in IgAN Patients Investor Calendar and Recordings
A Randomized Phase 2 Study of MAU868 vs Placebo to Treat BK Viremia in Kidney Transplant Recipients – Week 36 Results
